跳至主要内容
临床试验/NCT01100567
NCT01100567已完成不适用

EFFECT OF BIOMECHANICAL STIMULATION ON SKELETAL HEALTH IN ADOLESCENT AND YOUNG WOMEN WITH ANOREXIA NERVOSA

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2009年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
1
主要终点
Change From Baseline in C-telopeptides

研究概览

简要总结

This study will evaluate the effects of a novel, non-pharmacologic intervention for the prevention of deleterious changes in bone density and strength in adolescents with anorexia nervosa (AN), a disease commonly treated with extended periods of bed rest and immobilization. The primary focus of the trial is to conduct a prospective short-term intervention to prevent an uncoupling of bone turnover in inpatients hospitalized for AN, and to determine the long-term effects of a biomechanical intervention on skeletal health in ambulatory adolescents with AN.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
11 Years 至 25 Years(Child, Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age 11-25 years
  • •Diagnosis of anorexia nervosa based on DSM-IV criteria
  • •Female gender
  • •English-speaking

排除标准

  • •• Concomitant chronic diseases which affect bone health, such as cystic fibrosis, inflammatory bowel disease, celiac disease, renal disease, or diabetes mellitus
  • •Use of medications known to affect bone metabolism in the last 3 months, such as:
  • •Glucocorticoid therapy (including inhaled steroids)
  • •Anticonvulsants
  • •Combined estrogen/progestin contraceptive agents (oral contraceptive pills)
  • •Depot medroxyprogesterone (Depo-Provera) use in the last 12 months
  • •Current pregnancy

研究组 & 干预措施

Placebo platform

Placebo Comparator

Randomized to stand on placebo platform for 10 minutes/day

干预措施: Low-magnitude mechanical stimulation platform (Device)

Low-magnitude mechanical stimulation

Active Comparator

Randomized to stand on LMMS platform 10 minutes/daily

干预措施: Low-magnitude mechanical stimulation platform (Device)

结局指标

主要结局

Change From Baseline in C-telopeptides

时间窗: Baseline to 5 days

次要结局

  • Change From Baseline in Bone Specific Alkaline Phosphatase(baseline to 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amy DiVasta

Principal Investigator

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验

撤回
不适用
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNoncontiguous Stage II Grade 3 Follicular LymphomaChronic Eosinophilic LeukemiaAdult Acute Myeloid Leukemia in RemissionExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiableNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Adult Burkitt LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Mixed Cell LymphomaNoncontiguous Stage II Adult Immunoblastic Large Cell LymphomaAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Neutrophilic LeukemiaNoncontiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaNoncontiguous Stage II Grade 1 Follicular LymphomaNoncontiguous Stage II Mantle Cell LymphomaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Malignant Testicular Germ Cell TumorRecurrent Marginal Zone LymphomaAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Chronic Phase Chronic Myelogenous LeukemiaDisseminated NeuroblastomaNoncontiguous Stage II Grade 2 Follicular LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent NeuroblastomaStage III Adult Diffuse Mixed Cell LymphomaStage III Mantle Cell LymphomaStage IV Mantle Cell LymphomaStage IV Ovarian Epithelial CancerStage IV Small Lymphocytic LymphomaBlastic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesRecurrent Adult Lymphoblastic LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Small Lymphocytic LymphomaStage II Ovarian Germ Cell TumorStage III Chronic Lymphocytic LeukemiaStage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage IV Adult Burkitt LymphomaStage IV Marginal Zone LymphomaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesNoncontiguous Stage II Adult Lymphoblastic LymphomaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Ovarian Epithelial CancerChronic Myelomonocytic LeukemiaNoncontiguous Stage II Marginal Zone LymphomaNoncontiguous Stage II Small Lymphocytic LymphomaPlasma Cell NeoplasmPoor Prognosis Metastatic Gestational Trophoblastic TumorRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRefractory Chronic Lymphocytic LeukemiaSecondary Acute Myeloid LeukemiaSplenic Marginal Zone LymphomaStage II Ovarian Epithelial CancerStage III Adult Diffuse Small Cleaved Cell LymphomaStage III Adult Immunoblastic Large Cell LymphomaStage III Grade 3 Follicular LymphomaStage III Malignant Testicular Germ Cell TumorStage IIIA Breast CancerStage IIIC Breast CancerStage IV Adult Diffuse Large Cell LymphomaStage IV Adult Hodgkin LymphomaStage IV Adult Lymphoblastic LymphomaProlymphocytic LeukemiaRecurrent Mycosis Fungoides/Sezary SyndromeRecurrent Ovarian Germ Cell TumorSecondary Myelodysplastic SyndromesStage III Adult Burkitt LymphomaStage III Adult Hodgkin LymphomaStage III Marginal Zone LymphomaStage IIIB Breast CancerStage IV Adult Diffuse Small Cleaved Cell LymphomaStage IV Adult Immunoblastic Large Cell LymphomaStage IV Chronic Lymphocytic LeukemiaStage IV Grade 1 Follicular LymphomaStage IV Grade 2 Follicular LymphomaRefractory Hairy Cell LeukemiaRelapsing Chronic Myelogenous LeukemiaStage III Adult Diffuse Large Cell LymphomaStage III Adult Lymphoblastic LymphomaStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage III Small Lymphocytic LymphomaStage IV Adult Diffuse Mixed Cell LymphomaStage IV Breast CancerStage IV Grade 3 Follicular LymphomaStage IV Ovarian Germ Cell TumorPrimary Myelofibrosis
NCT01558778Roswell Park Cancer Institute
已完成
1 期
Mechanical Bone Stimulation and Adenosine 5'-Triphosphate (ATP) Release in HumansOsteoporosis
NCT01130428Maastricht University Medical Center10
尚未招募
1 期
Study on biomechanical mechanism and efficacy evaluation of Wei's two-step seven method for treatment of lumbar disc herniatioumbar disc herniation
ITMCTR2200005733The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine
已完成
不适用
The Effect of a New Biomechanical DeviceJoint ReplacementFracturesOsteoarthritis
NCT00767780Assaf-Harofeh Medical Center200
进行中(未招募)
2 期
Non-Invasive Stimulation for Improving Motor FunctionSpinal Cord Injuries
NCT03592173Kathleen Friel30